In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Invenra Inc.

www.invenra.com

Latest From Invenra Inc.

Tech Transfer Roundup: Mustang, Nationwide Children’s Hospital Collaborate In Pediatric Glioblastoma

Partnership will test Mustang’s MB-101 with a second-generation oncolytic HSV-1 virus for potential in treating brain cancer. Canadian biotech launched by CCAB to fight the same cancer.

Companies Deals

Out Of The Blocks, December 2012

Brief profiles of these recently formed companies: Invenra, Cibiem, PharmAria, Scholar Rock, Sengenix, and Visum Therapeutics.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Invenra Inc.
  • Senior Management
  • Roland Green, PhD, CEO
    Mark F Kubik, CBO
    Bryan Glaser, PhD, VP, Research
  • Contact Info
  • Invenra Inc.
    Phone: (608) 441-8319
    505 South Rosa Rd.
    Ste. 235
    Madison, WI 53719
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register